24 September 2020 - A group of pharmaceutical ­giants, biotech companies, industry peak bodies and the CSIRO have banded together to form an alliance to combat the “market failure” that inhibits the development of novel antibiotics to fight superbugs.

The Australian Antimicrobial Resistance Network — known as AAMRNet — will work to secure reforms aimed at incentivising antibiotic research and development in the face of an escalating crisis in which modern medicine is running out of ­options to treat drug-resistant infections.

The OECD has estimated that an average of 290 people die each year in Australia because of infections from eight resistant bacteria. It has predicted as many as 10,000 Australians will die because of antimicrobial resistance by 2050.

Read The Australian article